Pharmacological control of reproduction in mares requires the use of equine gonadotrophins to avoid induced immunological resistance. Crude equine gonadotrophins (CEG) 
Introduction
In equine species, the pharmacological control of reproduction requires the use of equine gonadotrophins: injections of heterologous hormone preparations lead to strong immune responses and, therefore, repeated treatments are inefficient (Roser et al, 1979; Bour, 1984) .
Until now, crude equine gonadotrophin (CEG) preparations from pituitaries containing both equine follicle-stimulating hor¬ mone (eFSH) and luteinizing hormone (eLH) have been used to induce the growth of multiple follicles in cyclic or anoestrous mares (Lapin and Ginther, 1977; Woods and Ginther, 1983) or to induce ovulation (Duchamp et al, 1987 (Chupín et al, 1984 (Combarnous and Hengé, 1981) and eLH (Guillou and Combarnous, 1983) (Guillou and Combarnous, 1983 ).
The antibodies used in the enzyme-linked immunosorbent assays (ELISA) were a rabbit anti-eFSH (803) antiserum charac¬ terized by Combarnous and Hengé (1981) for eFSH ELISA and a rabbit anti-PMSG serum characterized by Cahoreau and Combarnous (1987) for eLH ELISA.
Three batches of crude equine gonadotrophins (CEG-EX6, CEG-EX7 and CEG-EX9) were prepared as described by Guillou and Combarnous (1983 (Bousfield et al, 1987) injection (Duchamp et al, 1987 (Palmer and Driancourt, 1980) (Duchamp et al, 1987) . (2) (Fig. 2) (Combarnous and Hengé, 1981; Guillou and Combarnous 1983) and by others (Licht et al, 1979; Bousfield and Ward, 1984 
